Treating rhinitis by topically administering an epinastine solution to the nasal mucous membrane
Patent Information
- Authority / Receiving Office
- US · United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- TRACH VOLKER
- Publication Date
- 2007-08-09
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
RELATED APPLICATIONS
[0001] This application is a continuation of U.S. Ser. No. 10 / 271,180, filed Oct. 15, 2002, which is a continuation of U.S. Ser. No. 09 / 706,650, filed Nov. 6, 2000, now abandoned, which claims priority to German Application No. 199 54 516.2, filed Nov. 12, 1999, and claims benefit of U.S. Provisional Application Ser. No. 60 / 167,771, filed on Nov. 29, 1999, each of which is hereby incorporated by reference.FIELD OF THE INVENTION
[0002] The invention relates to topically administered aqueous solutions containing epinastine, optionally in the form of its racemates, its enantiomers, and optionally in the form of the pharmacologically acceptable acid addition salts thereof. BACKGROUND OF THE INVENTION
[0003] Allergic reactions of the eye (hereinafter referred to as ocular allergic reactions) signifies a series of differently defined syndromes. The following are examples of ocular allergic reactions, e.g., seasonal allergic conjunctivitis, perennial allergic conjuncti...